{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:20:16Z","timestamp":1783142416917,"version":"3.54.6"},"reference-count":26,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3960\/jslrt.26002","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T22:11:03Z","timestamp":1782598263000},"page":"122-129","source":"Crossref","is-referenced-by-count":0,"title":["&lt;i&gt;RHOA&lt;\/i&gt; G17V mutation analysis redirecting diagnosis: nodal T-follicular helper cell lymphoma with classic Hodgkin lymphoma feature"],"prefix":"10.3960","volume":"66","author":[{"given":"Rio","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori Filiz","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Nishikori","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Fukumi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Okayama City Hospital, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Ohsawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Momose","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Satou A, Takahara T, Nakamura S. An Update on the pathology and molecular features of Hodgkin lymphoma. Cancers (Basel). 2022; 14: 2647.","DOI":"10.3390\/cancers14112647"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Makita S, Maruyama D, Maeshima AM <i>et al.<\/i> Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma. Int J Hematol. 2016; 104: 236-244.","DOI":"10.1007\/s12185-016-2007-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Boo YL, Ting HSY, Yap DFS, Toh SG, Lim SM. Clinical features and treatment outcomes of Hodgkin lymphoma: A retrospective review in a Malaysian tertiary hospital. Blood Res. 2019; 54: 210-217.","DOI":"10.5045\/br.2019.54.3.210"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Advani RH, Skrypets T, Civallero M <i>et al.<\/i> Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell project. Blood. 2021; 138: 213-220.","DOI":"10.1182\/blood.2020010387"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Okazuka K, Shimizu T, Tawara R <i>et al.<\/i> Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patients. J Clin Exp Hematop. 2025; 65: 84-92.","DOI":"10.3960\/jslrt.24078"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kred\u00e1tusov\u00e1 AP, Prochazka V, Lukasova M <i>et al.<\/i> Progression of disease within 2 years predicts poor survival in patients with classic Hodgkin lymphoma. Blood. 2023; 142: 6194-6196.","DOI":"10.1182\/blood-2023-186562"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Hapgood G, Zheng Y, Sehn LH <i>et al.<\/i> Evaluation of the risk of relapse in classical Hodgkin lymphoma at event-free survival time points and survival comparison with the general population in British Columbia. J Clin Oncol. 2016; 34: 2493-2500.","DOI":"10.1200\/JCO.2015.65.4194"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Mourad N, Mounier N, Bri\u00e8re J <i>et al.<\/i> Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials. Blood. 2008; 111: 4463-4470.","DOI":"10.1182\/blood-2007-08-105759"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Sakata-Yanagimoto M, Enami T, Yoshida K <i>et al.<\/i> Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014; 46: 171-175.","DOI":"10.1038\/ng.2872"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Palomero T, Couronn\u00e9 L, Khiabanian H <i>et al.<\/i> Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014; 46: 166-170.","DOI":"10.1038\/ng.2873"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Petronilho S, Poullot E, Andre A <i>et al.<\/i> Follicular helper T-cell lymphoma with Hodgkin\/Reed-Sternberg-like cells versus classic Hodgkin lymphoma: A comparative study. Am J Surg Pathol. 2025; 49: 273-283.","DOI":"10.1097\/PAS.0000000000002345"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Attygalle AD, Cabe\u00e7adas J, Gaulard P <i>et al.<\/i> Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology. 2014; 64: 171-199.","DOI":"10.1111\/his.12251"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Naresh KN, Menasce LP, Shenjere P, Banerjee SS. \u2018Precursors\u2019 of classical Hodgkin lymphoma in samples of angioimmunoblastic T-cell lymphoma. Br J Haematol. 2008; 141: 124-126.","DOI":"10.1111\/j.1365-2141.2008.07004.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 van Dongen JJ, Langerak AW, Br\u00fcggemann M <i>et al.<\/i> Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003; 17: 2257-2317.","DOI":"10.1038\/sj.leu.2403202"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Dobson R, Du PY, R\u00e1s\u00f3-Barnett L <i>et al.<\/i> Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis. Haematologica. 2022; 107: 489-499.","DOI":"10.3324\/haematol.2020.265991"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Roemer MG, Advani RH, Ligon AH <i>et al.<\/i> PD-L1 and PD-L2 Genetic alterations define classical Hodgkin lymphoma and predict outcome. J Clin Oncol. 2016; 34: 2690-2697.","DOI":"10.1200\/JCO.2016.66.4482"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Ohsawa K, Momose S, Nishikori A <i>et al.<\/i> Copy number analysis of 9p24.1 in classic Hodgkin lymphoma arising in immune deficiency\/dysregulation. Cancers (Basel). 2024; 16: 1298.","DOI":"10.3390\/cancers16071298"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Nicolae A, Pittaluga S, Venkataraman G <i>et al.<\/i> Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol. 2013; 37: 816-826.","DOI":"10.1097\/PAS.0b013e3182785610"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Sakakibara A, Suzuki Y, Kato H <i>et al.<\/i> Follicular T-cell lymphoma mimicking lymphocyte-rich classic Hodgkin lymphoma: a case report of a diagnostic pitfall. J Clin Exp Hematop. 2021; 61: 97-101.","DOI":"10.3960\/jslrt.20052"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Qian J, Meng H, Lv B <i>et al.<\/i> High expression levels of TLR9 and PD-L1 indicates a poor prognosis in patients with angioimmunoblastic T-cell lymphoma: a retrospective study of 88 cases in a single center. J Cancer. 2020; 11: 57-68.","DOI":"10.7150\/jca.37033"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Satou A, Takahara T, Yamashita D <i>et al.<\/i> Diagnostic Utility of STAT6 and pSTAT6 Immunohistochemistry for distinguishing classic Hodgkin lymphoma and peripheral T-Cell lymphoma with Hodgkin and reed-sternberg-like cells. Am J Surg Pathol. 2023; 47: 897-906.","DOI":"10.1097\/PAS.0000000000002062"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Xie Y, Jaffe ES. How I diagnose angioimmunoblastic T-Cell lymphoma. Am J Clin Pathol. 2021; 156: 1-14.","DOI":"10.1093\/ajcp\/aqab090"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Ganapathi KA, Karner KH, Menon MP. Peripheral T-Cell lymphomas of the T follicular helper type. Hemato. 2022; 3: 268-286.","DOI":"10.3390\/hemato3010020"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Abukhiran I, Syrbu SI, Holman CJ. Markers of Follicular helper T cells Are occasionally expressed in T-cell or histiocyte-rich large B-cell lymphoma, classic Hodgkin lymphoma, and atypical paracortical hyperplasiaa diagnostic pitfall For T-cell lymphomas of T follicular helper origin. Am J Clin Pathol. 2021; 156: 409-426.","DOI":"10.1093\/ajcp\/aqaa249"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Eladl AE, Shimada K, Suzuki Y <i>et al.<\/i> EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma. Cancer Med. 2020; 9: 678-688.","DOI":"10.1002\/cam4.2742"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Gion Y, Doi M, Nishimura Y <i>et al.<\/i> PD-L1 expression is associated with the spontaneous regression of patients with methotrexate-associated lymphoproliferative disorders. Cancer Med. 2022; 11: 417-432.","DOI":"10.1002\/cam4.4462"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/2\/66_26002\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:13:36Z","timestamp":1783142016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/2\/66_26002\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.26002","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"26002"}}